Progress, Potential, and Possibilities Podcast / Show · 2026-05-01 · 45 min
Send us Fan Mail Today on Progress, Potential And Possibilities, we explore a different kind of breakthrough in cognitive health - not a drug, not a device, but a simple daily practice that’s quietly transforming lives. Our guest is Rob Liebreich, President and CEO of Goodwin Living ( ), an organization serving thousands of older adults across the Washington, D.C. region. Rob has spent more than two decades at the forefront of senior living and aging services - leading large-scale communities, building platforms to improve how families navigate care decisions, and working to fundamentally shift the narrative around aging from one of decline to one of purpose and possibility. But this story isn’t just professional - it’s deeply personal. When Rob’s mother began experiencing cognitive decline, he refused to accept that deterioration was inevitable. Drawing on both his industry experience and a willingness to experiment, he developed a simple daily regimen - reading aloud, handwriting, and doing math - that helped her regain engagement, confidence, and independence.
Other episodes covering the same guests and topics, from across The B2B Podcast Index.
When High Performers Break: The Science of Staying SteadyTeamwork - A Better Way · on Neuroplasticity85 / 100
"I Learn, Therefore I Evolve": Rethinking Human Learning in the Age of AI (ft. Dr. Barbara Oakley)2050 Investors · on Neuroplasticity78 / 100
Aneesh Raman: AI won't decide the future of work - unless you let itWorkLab · on Neuroplasticity77 / 100
S:8 E:2: Neuroplastic AI modelsIoT Unplugged · on Neuroplasticity75 / 100
Psychedelics Might Be the Future of Mental Health | Althea CEO, Niko SkievaskiBoundary Breakers · on Neuroplasticity73 / 100
Building the Future of Brain Training with EEG Headphones - with John Golden, CEO of Vital NeuroProduct in Healthtech · on Neuroplasticity64 / 100Building the Internet of Medicine: How AI Could Transform Children's Healthcare | Dr. Timothy Chou - Founder, Pediatric Moonshot92 / 100The Blood Test That Could Change Cancer Treatment Forever | Eric Matthews - General Manager, Biopharma, Natera65 / 100How Female Biology Shapes Skin Disease Across a Lifetime | Dr. Doral Fredericks, PharmD, MBA - Vice President and Head of Global Medical Affairs and Outcomes Research, Organon56 / 10055 Years Without a Diagnosis | Can AI Solve The Undiagnosed Condition Blind Spot? | Haresh Patel - Founder and CEO, Sanare Health AI70 / 100How Regenerative Medicine Is Reinventing Breast Reconstruction | Dr. Claudia Chavez-Munoz, MD, PhD - Chief Scientific Officer and Co-Founder - Conexeu Sciences